Hence, our data indicate that a complex interplay between different ERs and transduction pathways contributes to atrazine activity, which nevertheless is still noticeable in the presence of GPR30 alone, as demonstrated in SkBr3 breast cancer cells. This evidence concerns the gene GPER1 and breast cancer.